Stock listing

NASDAQ:TCRR Tcr2 Therapeutics Inc Stock

Follow Tcr2 Therapeutics Inc into a list and get an email when it puts out news.

Last close · NASDAQ:TCRR

$1.48 USD

Close on Jun 1, 2023 · No longer trades

Feb 14, 2019 to last close -90.2% · weekly closes, Feb 14, 2019 – Jun 1, 2023
Lowest – highest close
$0.83 – $34.07 USDSince Feb 14, 2019 · lowest Dec 22, 2022 · highest Jan 12, 2021

Delisted NASDAQ:TCRR no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:TCRR
Asset type
Stock
Exchange
NASDAQ
Currency
USD

Tcr2 Therapeutics Inc on 6ix

Decks
6 decks · latest Mar 6, 2023

Decks

DeckKindSlidesDate
Merger or Acquisition (March 2023)Merger or acquisition36 slidesMar 6, 2023
Technical Presentation (September 2022)Technical34 slidesSep 28, 2022
Investor Day (October 2021)Investor day65 slidesOct 20, 2021
Technical Presentation (September 2021)Technical20 slidesSep 17, 2021
Corporate Update (December 2020)Corporate update21 slidesDec 14, 2020
Technical Presentation (July 2020)Technical27 slidesJul 27, 2020

Open Decks

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Stephen Webster
Other companies: Cullinan Therapeutics, Inc. (Chair of the Audit Committee · Since at least Jan 7, 2021); NextCure, Inc. (Director · Since at least May 8, 2019); Gritstone bio, Inc. (Director · Apr 26, 2024 – Apr 4, 2025 · Past); Nabriva Therapeutics AG (Director · Dec 30, 2016 – Aug 2, 2022 · Past); Viking Therapeutics, Inc. (Director · Apr 28, 2015 – Jan 2, 2020 · Past); Spark Therapeutics Inc (CHIEF FINANCIAL OFFICER · Jan 29, 2015 – Dec 17, 2019 · Past); Optimer Pharmaceuticals Inc (Chief Financial Officer · Jun 25, 2012 – Oct 24, 2013 · Past); Adolor Corp (SVP, Finance & CFO · Sep 9, 2010 – Dec 12, 2011 · Past)
Director · Apr 30, 2020 – Jun 1, 2023 · Past
Garry E. Menzel
Other companies: Adaptimmune Therapeutics PLC (Non-Executive Director · Since at least Jun 1, 2023); Stoke Therapeutics, Inc. (Director · Since at least Aug 13, 2020); Black Diamond Therapeutics, Inc. (Operating Partner, GHO Capital Partners LLP · Since at least Jan 29, 2020); DaVita Inc. (Senior Vice President, Finance · Sep 9, 2013 – Sep 9, 2013 · Past); Regulus Therapeutics Inc (COO & Executive VP, Finance · Oct 4, 2012 – Dec 11, 2012 · Past)
President and CEO, Director · Feb 13, 2019 – Jun 1, 2023 · Past
Mitchell H Finer
Other companies: PepGen Inc. (Director · Since at least Mar 27, 2025); Turmeric Acquisition Corp (Director · Oct 15, 2020 – Oct 15, 2020 · Past); Oncorus Inc (Director · Oct 1, 2020 – Jun 23, 2022 · Past); Adverum Biotechnologies Inc (Director · May 11, 2016 – Jul 31, 2019 · Past); Bluebird bio Inc (Chief Scientific Officer · Jun 18, 2013 – Jun 1, 2015 · Past)
Director · Feb 13, 2019 – Feb 13, 2019 · Past
Shawn Tomasello
Other companies: Cabaletta Bio, Inc. (Director · Since at least Jul 21, 2023); 4D Molecular Therapeutics, Inc. (Director · Since at least Dec 10, 2020); Kalaris Therapeutics, Inc. (Director · Mar 29, 2022 – Jun 6, 2024 · Past); Gamida Cell Ltd (Director · Jan 1, 2022 – Jan 31, 2024 · Past); UroGen Pharma Ltd. (Director · Jun 7, 2021 – Jun 7, 2021 · Past)
Director · Feb 3, 2021 – Jun 1, 2023 · Past
Neil Gibson
Other companies: Instil Bio, Inc. (Board Member · Since at least Mar 18, 2021); Shattuck Labs, Inc. (Director · Since at least Oct 8, 2020); Regulus Therapeutics Inc (Chief Scientific Officer · Oct 4, 2012 – Jan 28, 2015 · Past)
Director · Feb 13, 2019 – Jun 1, 2023 · Past
Morana Jovan-Embiricos
Other companies: Kalaris Therapeutics, Inc. (Director · Since at least Jul 29, 2020); Cullinan Therapeutics, Inc. (Director · Jan 7, 2021 – Sep 16, 2021 · Past)
Director · Feb 13, 2019 – Feb 19, 2019 · Past
Mayur Ian Somaiya
Other companies: NewAmsterdam Pharma Company N.V. (Chief Financial Officer · Since at least Dec 29, 2023)
Chief Financial Officer · Feb 13, 2019 – Dec 14, 2020 · Past
Robert Hofmeister
Other companies: Alaunos Therapeutics, Inc. (Director · Mar 30, 2023 – Jun 6, 2024 · Past)
Chief Scientific Officer · Oct 29, 2020 – Dec 9, 2021 · Past
Rosemary Harrison
Other companies: Trillium Therapeutics Inc (See Remarks · Jan 1, 2021 – Nov 17, 2021 · Past)
Chief Business & Strategy · Jan 10, 2022 – Jun 1, 2023 · Past
Axel HoosDirector · Apr 13, 2020 – Jun 1, 2023 · Past

Open People

Log in to ask 6ix AI your own questions about Tcr2 Therapeutics Inc.